http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#Head
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#assertion
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#provenance
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#pubinfo
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#assertion
http://purl.obolibrary.org/obo/DOID_8567
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_8567
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB08870
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association
http://www.w3.org/2000/01/rdf-schema#label
adcetris is a cd3 directed antibody drug conjugate indicated for treatment of adult patients with previously untreated stage iii or iv classical hodgkin lymphoma chl in combination with doxorubicin vinblastine and dacarbazine 1 1 classical hodgkin lymphoma chl at high risk of relapse or progression as post autologous hematopoietic stem cell transplantation auto hsct consolidation 1 2 classical hodgkin lymphoma chl after failure of auto hsct or after failure of at least two prior multi agent chemotherapy regimens in patients who are not auto hsct candidates 1 3 previously untreated systemic anaplastic large cell lymphoma salcl or other cd3 expressing peripheral t cell lymphomas ptcl including angioimmunoblastic t cell lymphoma and ptcl not otherwise specified in combination with cyclophosphamide doxorubicin and prednisone 1 4 systemic anaplastic large cell lymphoma salcl after failure of at least one prior multi agent chemotherapy regimen 1 5 primary cutaneous anaplastic large cell lymphoma pcalcl or cd3 expressing mycosis fungoides mf who have received prior systemic therapy 1 6 adcetris is indicated for the treatment of adult patients with previously untreated stage iii or iv chl in combination with doxorubicin vinblastine and dacarbazine adcetris is indicated for the treatment of adult patients with chl at high risk of relapse or progression as post autologous hematopoietic stem cell transplantation auto hsct consolidation adcetris is indicated for the treatment of adult patients with chl after failure of auto hsct or after failure of at least two prior multi agent chemotherapy regimens in patients who are not auto hsct candidates adcetris is indicated for the treatment of adult patients with previously untreated salcl or other cd3 expressing ptcl including angioimmunoblastic t cell lymphoma and ptcl not otherwise specified in combination with cyclophosphamide doxorubicin and prednisone adcetris is indicated for the treatment of adult patients with salcl after failure of at least one prior multi agent chemotherapy regimen adcetris is indicated for the treatment of adult patients with pcalcl or cd3 expressing mf who have received prior systemic therapy
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB08870
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#provenance
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#pubinfo
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#sig
http://purl.org/nanopub/x/hasSignature
WImQ4v4cYgPava3wn/U00F+zkAZScY+5lpGGJP3feXQHEujl7OPjX54IBfnHV7meMVssTRLnI4JdqJOmqu45qFk90HwvAduYkX6Na85pfd8B1QgNYb4lgFUazz6b2SUy88Oec1jPIPlAs4ncgtVMZweu2ly6TQVdllaXYCniZ2Y=
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8
http://purl.org/dc/terms/created
2021-07-03T14:58:06.103+02:00
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs